Risk assessment of readmissions following an initial COPD-related hospitalization
Christine L Baker,1 Kelly H Zou,1 Jun Su2 1Pfizer Inc, New York, NY, USA; 2Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA Background: Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a leading cause of hospitalizations and readmissions in the US. Reducing the freq...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-11-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/risk-assessment-of-readmissions-following-an-initial-copd-related-hosp-a14965 |